Android app on Google Play

Pfizer (PFE) Enters Settlement with Impax (IPXL) Over Detrol LA Application

August 23, 2012 4:39 PM EDT Send to a Friend
Pfizer Inc. (NYSE: PFE) is ticking higher in late trading Thursday following reports that it settled litigation with Impax Labs (Nasdaq: IPXL).

According to Bloomberg, Pfizer and Impax settled a patent lawsuit over an application for the generic form of Detrol LA.

Detrol LA is a bladder-control treatment.

Terms of the settlement weren't disclosed.




You May Also Be Interested In


Related Categories

Corporate News, FDA, Litigation

Add Your Comment